Cargando…

The impact of the COVID-19 pandemic on the incidence of herpes zoster: Nicolas Lecrenier

BACKGROUND: There have been several case reports of herpes zoster (HZ) following COVID-19 disease and vaccination. We conducted a non-systematic literature search to elucidate the global effects of the COVID-19 pandemic on the incidence of HZ. METHODS: The literature search was performed in October...

Descripción completa

Detalles Bibliográficos
Autores principales: Lecrenier, N, Parikh, R, Wang, C, Curran, D, Widenmaier, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593448/
http://dx.doi.org/10.1093/eurpub/ckac131.204
_version_ 1784815162476199936
author Lecrenier, N
Parikh, R
Wang, C
Curran, D
Widenmaier, R
author_facet Lecrenier, N
Parikh, R
Wang, C
Curran, D
Widenmaier, R
author_sort Lecrenier, N
collection PubMed
description BACKGROUND: There have been several case reports of herpes zoster (HZ) following COVID-19 disease and vaccination. We conducted a non-systematic literature search to elucidate the global effects of the COVID-19 pandemic on the incidence of HZ. METHODS: The literature search was performed in October 2021 using PubMed and Embase. The search string was herpes zoster AND COVID-19. Publications were manually reviewed; case reports were removed. RESULTS: Three retrospective studies reported the risk of HZ following COVID-19 disease. One study (Bhavsar, 2021) used two US databases and found higher risk of HZ following COVID-19 disease (relative risk [RR]=1.15) and COVID-19 hospitalisation (RR = 1.21), respectively. A strong association between HZ and COVID-19 disease (RR = 5.27) was also reported in a study of the University of Florida patient registry (Katz, 2021). The third study (Barda, 2021) reported no association between COVID-19 disease and risk of HZ (RR = 0.82). In two of the three observational studies in Israel (Furer, 2021 and Barda, 2021), the incidence of HZ was increased following COVID-19 vaccination. The third study (Shasha, 2021) found no association (RR = 1.07). Other studies included a report in Brazil (Maia, 2021) that demonstrated a 35% increase in HZ diagnoses during the pandemic versus pre-pandemic and a published model (La, 2021) that estimated the declining uptake of recombinant zoster vaccine in the US may result in 63,117 avoidable HZ cases in those who remain unvaccinated in 2021. CONCLUSIONS: Emerging data suggest that the COVID-19 pandemic may have increased the risk of HZ and negatively impacted HZ vaccine uptake. Therefore, there is an important need to increase awareness of HZ and HZ vaccination during the pandemic. KEY MESSAGES: • There is a need to increase awareness of HZ and HZ vaccination during the COVID-19 era. • Further studies are needed to fully understand the impact of COVID-19 on the risk of HZ.
format Online
Article
Text
id pubmed-9593448
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95934482022-11-04 The impact of the COVID-19 pandemic on the incidence of herpes zoster: Nicolas Lecrenier Lecrenier, N Parikh, R Wang, C Curran, D Widenmaier, R Eur J Public Health Poster Displays BACKGROUND: There have been several case reports of herpes zoster (HZ) following COVID-19 disease and vaccination. We conducted a non-systematic literature search to elucidate the global effects of the COVID-19 pandemic on the incidence of HZ. METHODS: The literature search was performed in October 2021 using PubMed and Embase. The search string was herpes zoster AND COVID-19. Publications were manually reviewed; case reports were removed. RESULTS: Three retrospective studies reported the risk of HZ following COVID-19 disease. One study (Bhavsar, 2021) used two US databases and found higher risk of HZ following COVID-19 disease (relative risk [RR]=1.15) and COVID-19 hospitalisation (RR = 1.21), respectively. A strong association between HZ and COVID-19 disease (RR = 5.27) was also reported in a study of the University of Florida patient registry (Katz, 2021). The third study (Barda, 2021) reported no association between COVID-19 disease and risk of HZ (RR = 0.82). In two of the three observational studies in Israel (Furer, 2021 and Barda, 2021), the incidence of HZ was increased following COVID-19 vaccination. The third study (Shasha, 2021) found no association (RR = 1.07). Other studies included a report in Brazil (Maia, 2021) that demonstrated a 35% increase in HZ diagnoses during the pandemic versus pre-pandemic and a published model (La, 2021) that estimated the declining uptake of recombinant zoster vaccine in the US may result in 63,117 avoidable HZ cases in those who remain unvaccinated in 2021. CONCLUSIONS: Emerging data suggest that the COVID-19 pandemic may have increased the risk of HZ and negatively impacted HZ vaccine uptake. Therefore, there is an important need to increase awareness of HZ and HZ vaccination during the pandemic. KEY MESSAGES: • There is a need to increase awareness of HZ and HZ vaccination during the COVID-19 era. • Further studies are needed to fully understand the impact of COVID-19 on the risk of HZ. Oxford University Press 2022-10-25 /pmc/articles/PMC9593448/ http://dx.doi.org/10.1093/eurpub/ckac131.204 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Displays
Lecrenier, N
Parikh, R
Wang, C
Curran, D
Widenmaier, R
The impact of the COVID-19 pandemic on the incidence of herpes zoster: Nicolas Lecrenier
title The impact of the COVID-19 pandemic on the incidence of herpes zoster: Nicolas Lecrenier
title_full The impact of the COVID-19 pandemic on the incidence of herpes zoster: Nicolas Lecrenier
title_fullStr The impact of the COVID-19 pandemic on the incidence of herpes zoster: Nicolas Lecrenier
title_full_unstemmed The impact of the COVID-19 pandemic on the incidence of herpes zoster: Nicolas Lecrenier
title_short The impact of the COVID-19 pandemic on the incidence of herpes zoster: Nicolas Lecrenier
title_sort impact of the covid-19 pandemic on the incidence of herpes zoster: nicolas lecrenier
topic Poster Displays
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593448/
http://dx.doi.org/10.1093/eurpub/ckac131.204
work_keys_str_mv AT lecreniern theimpactofthecovid19pandemicontheincidenceofherpeszosternicolaslecrenier
AT parikhr theimpactofthecovid19pandemicontheincidenceofherpeszosternicolaslecrenier
AT wangc theimpactofthecovid19pandemicontheincidenceofherpeszosternicolaslecrenier
AT currand theimpactofthecovid19pandemicontheincidenceofherpeszosternicolaslecrenier
AT widenmaierr theimpactofthecovid19pandemicontheincidenceofherpeszosternicolaslecrenier
AT lecreniern impactofthecovid19pandemicontheincidenceofherpeszosternicolaslecrenier
AT parikhr impactofthecovid19pandemicontheincidenceofherpeszosternicolaslecrenier
AT wangc impactofthecovid19pandemicontheincidenceofherpeszosternicolaslecrenier
AT currand impactofthecovid19pandemicontheincidenceofherpeszosternicolaslecrenier
AT widenmaierr impactofthecovid19pandemicontheincidenceofherpeszosternicolaslecrenier